Alison Oneill

Insider Reports History

Signature
/s/ Jessica Fees, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Alison Oneill:

Company Role Class Num Shares Value Price $ Report Date Ownership
Surface Oncology, Inc. Chief Medical Officer Common Stock 0 $0.9400 08 Sep 2023 Direct
Surface Oncology, Inc. Chief Medical Officer Stock Option (Right to Buy) 0 08 Sep 2023 Direct

Insider Reports Filed by Alison Oneill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123048754-oneill-alison-2023-09-08 Surface Oncology, Inc. 08 Sep 2023 2 $0 4 Chief Medical Officer 08 Sep 2023, 16:00
/report/000120919123045497-oneill-alison-2023-08-01 Surface Oncology, Inc. 01 Aug 2023 1 -$6,619 4 Chief Medical Officer 11 Aug 2023, 20:00
/report/000120919123016050-oneill-alison-2023-03-01 Surface Oncology, Inc. 01 Mar 2023 1 $0 4 Chief Medical Officer 03 Mar 2023, 19:00
/report/000120919122044674-oneill-alison-2022-08-03 Surface Oncology, Inc. 03 Aug 2022 1 -$7,676 4 Chief Medical Officer 05 Aug 2022, 20:01
/report/000120919122015963-oneill-alison-2022-03-01 Surface Oncology, Inc. 01 Mar 2022 2 $0 4 Chief Medical Officer 03 Mar 2022, 19:00
/report/000120919122003395-oneill-alison-2020-03-01 Surface Oncology, Inc. 01 Mar 2020 2 -$90,335 4 Chief Medical Officer 14 Jan 2022, 19:30